Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms

Acta Diabetologica

Volumn 50, Issue 2, 2013, Pages 163-173

  Wang, An Ping ^a   Li, Xia ^a   Zheng, Ying ^a   Liu, Bi Lian ^a   Huang, Gan ^a   Yan, Xiang ^a   Liu, Zhenqi ^b   Zhou, Zhiguang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Caspase 3; Diabetes; TZDs

Indexed keywords

CASPASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE;

ANIMAL CELL; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; INSULIN RELEASE; INSULIN RESPONSE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE INHIBITORS; CELL LINE; CYTOKINES; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; MICE; MICE, TRANSGENIC; PPAR GAMMA; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES; TRANSFECTION;

EID: 84880918987     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0239-8     Document Type: Article

References (50)

1. Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M, Baschal E, Yu L, Babu S, Dawson A, Johnson K, Jahromi M, Aly T, Fain P, Barker J, Rewers M, Eisenbarth GS (2008) Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp 292:85-94
2. Rossini AA (2004) Autoimmune diabetes and the circle of tolerance. Diabetes 53:267-275
3. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death: the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115-2133
4. Hui H, Dotta F, Di Mario U, Perfetti R (2004) Role of caspases in the regulation of apoptotic pa ncreatic islet β- cells death. J Cell Physiol 200:177-200
5. Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P (2000) Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739-742
6. Atz JD, Benoist C, Mathis D (1995) T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188
7. Eizirik DL, Darville MI (2001) Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 50(Suppl 1):S64-S69
8. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97-S107
9. Campbell IL, Kay TW, Oxbrow L, Harrison LC (1991) Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742
10. Krishnamurthy B, Dudek NL, McKenzie MD, Purcell AW, Brooks AG, Gellert S, Colman PG, Harrison LC, Lew AM, Thomas HE, Kay TW (2006) Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J Clin Invest 116:3258-3265
11. O'Sullivan BJ, Thomas HE, Pai S, Santamaria P, Iwakura Y, Steptoe RJ, Kay TW, Thomas R (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278-7287
12. Thomas HE, Irawaty W, Darwiche R, Brodnicki TC, Santamaria P, Allison J, Kay TW (2004) IL-1 receptor deficiency slows progression to diabetes in the NOD mouse. Diabetes 53:113-121
13. Wang B, Andre I, Gonzalez A, Katz JD, Aguet M, Benoist C, Mathis D (1997) Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc Natl Acad Sci USA 94:13844-13849
14. Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE, Chariot A, Orntoft TF, Eizirik DL (2008) Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic beta cells. Diabetologia 51:1213-1225
15. Kim S, Millet I, Kim HS, Kim JY, Han MS, Lee MK, Kim KW, Sherwin RS, Karin M, Lee MS (2007) NF-κB prevents beta cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 104:1913-1918
16. Philchenkov A (2004) Caspases: potential targets for regulating cell death. J Cell Mol Med 8:432-444
17. Zhang B, Lu Y, Campbell-Thompson M (2007) α1-antitrypsin protects β-cells from apoptosis. Diabetes 56:1316-1323
18. Krammer PH (1999) CD95 (Apo-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 71:163-210
19. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789-795
20. Odom J, Williamson B, Carter L (2008) Rosiglitazone and pioglitazone in the treatment of diabetes mellitus. Am J Health-Syst Pharm 65:1846-1850
21. Villacorta L, Schopfer FJ, Zhang J, Freeman BA, Chen YE (2009) PPARgamma and its ligands: therapeutic implications in cardiovascular disease. Clin Sci (Lond) 116:205-218
22. Hazra S, Batra RK, Tai HH (2007) Pioglitazone and rosiglitazone decrease pros- taglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxy- prostaglandin dehydrogenase. Mol Pharmacol 71:1715-1720
23. Artwohl M, Fürnsinn C, Waldhäusl W (2005) Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanism. Diabetologia 48:586-594
24. Gardner OS, Shiau CW, Chen CS (2005) Peroxisome proliferator- activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves cal- cium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress. J Biol Chem 280:10109-10118
25. Wei S, Yang J, Lee SL, Kulp SK, Chen CS (2009) PPARgamma-independent antitumor effects of thiazolidinediones. Cancer Lett 276:119-124
26. Xiong X, Ye Y, Fu L, Dai B, Liu J, Jia J, Tang J, Li L, Wang L, Shen J, Mei C (2009) Antitumor activity of a novel series of alpha-aryloxy-alpha- methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines. Invest New Drugs 27:223-232
27. Dewar BJ, Gardner OS, Chen CS, Earp HS, Samet JM, Graves LM (2007) Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones. Mol Pharmacol 72:1146-1156
28. Weng JR, Chen CY, Pinzone JJ, Ringel MD, Chen CS (2006) Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones. Endocr Relat Cancer 13:401-413
29. Tsukamoto H, Hishinuma T, Suzuki N, Tayama R, Hiratsuka M, Yoshihisa T, Mizugaki M, Goto J (2004) Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor gamma-independent manner. Prostaglandins Other Lipid Mediat 3:191-213
30. Rosen ED, Kulkarni RN, Sarraf P, Ozcan U, Okada T, Hsu CH, Eisenman D, Magnuson MA, Gonzalez FJ, Kahn CR, Spiegelman BM (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormal- ities in islet mass without compromising glucose homeostasis. Mol Cell Biol 23:7222-7229
31. Kim E-K, Kwon K-B, Koo B-S, Han M-J, Song M-Y, Song E-K, Han M-K, Park J-W, Ryu D-G, Park B-H (2007) Activation of peroxisome proliferators-activated receptor-γ protects pancreatic β-cells from cytokine- induced cytotoxicity via NFkB pathway. Int J Biochem Cell Biol 39:1260-1275
32. Pei J, Zhou Z, Luo J, Jiang T, Li X, He L (2004) Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mice. National Medical Journal of China 84:411-415
33. Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, Wang J (2005) Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 21:203-208
34. Kwon KB, Yang JY, Ryu DG, Rho HW, Kim JS, Park JW, Kim HR, Park BH (2001) Vibrio vulnificus cytolysin induces superoxide anion initiated apoptotic signaling pathway in human ECV304 cells. J Biol Chem 276:47518-47523
35. Oyadomari S, Takeda K, Takiguchi M, Gotoh T, Matsumoto M, Wada I, Akira S, Araki E, Mori M (2001) Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA 98:10845-10850
36. Deng WG, Zhu Y, Wu KK (2004) 2004 Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103:2135-2142
37. Lin TN, Cheung WM, Wu JS, Chen JJ, Lin H, Chen JJ, Liou JY, Shyue SK, Wu KK (2006) 15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26:481-487
38. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
39. Park BH, Rho HW, Park JW, Cho CG, Kim JS, Chung HT, Kim HR (1995) Protective mechanism of glucose against alloxan induced pancreatic β-cell damage. Biochem Biophys Res Commun 210:1-6
40. Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788-791
41. Lin CY, Gurlo T, Haataja L, Hsueh WA, Butler PC (2005) Activation of peroxisome proliferator- activated receptor gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase- dependent pathway. J Clin Endocrinol Metab 90:6678-6686
42. Weber SM, Scarim AL, Corbett JA (2004) PPARγ, is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic cells. Am J Physiol Endocrinol Metab 286:E329-E336
43. Oshima H, Taketo MM, Oshima M (2006) Destruction of pancreatic β-cells by transgenic induction of prostaglandin E2 in the islets. J Biol Chemistry 281:29330-29336
44. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic- reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-103
45. Augstein P, Heinke P, Salzsieder E, Grimm R, Giebel J, Salzsieder C, Harrison LC (2008) Dominance of cytokine-over FasL-induced impairment of the mitochondrial transmembrane potential (Δψm) in the pancreatic β-cell line NIT-1. Diabetes Vasc Dis Res 5:198-204
46. Pavlovic D, Andersen NA, Mandrup-Poulsen T, Eizirik DL (2000) Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic β-cells. Eur Cytokine Netw 11:267-274
47. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patané G, Boggi U, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437-1442
48. Aouad SM, Cohen LY, Sharif-Askari E, Haddad EK, Alam A, Sekaly RP (2004) Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. J Immunol 172:2316-2323
49. Yamada K, Ichikawa F, Ishiyama SS, Yuan X, Nonaka K (1999) Essential role of caspases-3 in apoptosis of mouse beta-cells transfected with human Fas. Diabetes 48:478-483
50. Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, Woo M (2005) Caspase-3-dependent cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25:3620-3629